Wednesday 14 October 2026
Export CI’s income statement to Excel — free account
Cigna Group
CI Healthcare Healthcare Plans
Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 6.68%, EPS grew 10.2%, free cash flow grew 66.9% and total debt rose 3.61%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.
282.53
0.81
−0.29%
Follow CI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
9 | 8 | 8 | 8 |
| 14.58% | 14.33% | 15.18% | 15.40% | ||
| 3.90% | 3.80% | 4.14% | 4.16% | ||
ROIC |
8.06% | 8.76% | 9.04% | 9.09% | |
Return on Tangible Assets |
(56.59%) | (49.05%) | (56.23%) | (59.71%) | |
Average Days of Receivables |
48.90 | 43.64 | 40.30 | 44.96 | |
Free Cash Flow per Share |
27.97 | 31.45 | 29.15 | 34.65 | |
Free Cash Flow |
7,437.00 | 8,389.00 | 7,660.00 | 9,113.00 | |
Capital Expenditures |
(1,227.00) | (1,212.00) | (1,152.00) | (1,164.00) | |
| Other line items | |||||
Cash ROIC |
9.06% | 10.36% | 9.53% | 11.24% | |
Accounts Receivable Turnover |
7.85 | 8.94 | 8.97 | 8.04 | |
Accounts Payable Turnover |
0.94 | 0.87 | 0.87 | 0.85 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
399.15 | 435.59 | 409.42 | 411.99 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.18) | (0.19) | (0.20) | (0.19) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
5.55% | 5.32% | 5.08% | 5.02% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
6.41 | 6.53 | 6.83 | 7.00 | |
Operating CF/Net income |
1.41 | 1.61 | 1.40 | 1.60 | |
Depreciation/Fixed assets |
0.74 | 0.76 | 0.74 | 0.73 | |
Capex/Depreciation |
(0.45) | (0.44) | (0.42) | (0.43) | |
Revenue per Share |
1,008.14 | 1,030.58 | 1,057.65 | 1,073.75 | |
Operating CF per Share |
32.58 | 35.99 | 33.54 | 39.08 | |
Capex per Share |
(4.61) | (4.54) | (4.38) | (4.43) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates